Cargando…
Monoaminergic System Modulation in Depression and Alzheimer’s Disease: A New Standpoint?
The prevalence of depression has dramatically increased, and it has been estimated that over 300 million people suffer from depression all over the world. Depression is highly comorbid with many central and peripheral disorders. In this regard, depressive states have been associated with the develop...
Autores principales: | Morgese, Maria Grazia, Trabace, Luigia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533589/ https://www.ncbi.nlm.nih.gov/pubmed/31156428 http://dx.doi.org/10.3389/fphar.2019.00483 |
Ejemplares similares
-
Precision Medicine in Alzheimer’s Disease: Investigating Comorbid Common Biological Substrates in the Rat Model of Amyloid Beta-Induced Toxicity
por: Morgese, Maria Grazia, et al.
Publicado: (2022) -
Maternal Malnutrition in the Etiopathogenesis of Psychiatric Diseases: Role of Polyunsaturated Fatty Acids
por: Morgese, Maria Grazia, et al.
Publicado: (2016) -
Effects of anabolic-androgens on brain reward function
por: Mhillaj, Emanuela, et al.
Publicado: (2015) -
Special Issue “Potential Neuromodulatory Profile of Phytocompounds in Brain Disorders”
por: Trabace, Luigia, et al.
Publicado: (2016) -
The Therapeutic Potential of Celastrol in Central Nervous System Disorders: Highlights from In Vitro and In Vivo Approaches
por: Schiavone, Stefania, et al.
Publicado: (2021)